Evaluating the technical feasibility of serological testing and treatment for Plasmodium vivax in mobile at-risk of malaria Cambodian populations
The PvSeroTAT interventions received funding from the Global Fund RAI3 initiative. Cross-sectional surveys were funded by the NIH International Centers of Excellence for Malaria Research (ICEMR) Asia-Pacific (U19AI129392).
Authors
- Nimol Khim (ORCID: https://orcid.org/0000-0002-4307-788X)
- Ivo Müeller (ORCID: https://orcid.org/0000-0001-6554-6889)
- Ágnes Orbán (ORCID: https://orcid.org/0000-0001-5865-2106)
- Rhea J. Longley (ORCID: https://orcid.org/0000-0002-4510-5602)
- Costanza Tacoli (ORCID: https://orcid.org/0000-0002-9052-5681)
- Michael White (ORCID: https://orcid.org/0000-0002-7472-4138)
- Dysoley Lek
- Leanne J. Robinson (ORCID: https://orcid.org/0000-0001-9903-1023)
- Jean Popovici (ORCID: https://orcid.org/0000-0002-3135-1175)
- Benoît Witkowski (ORCID: https://orcid.org/0000-0002-8599-6382)
- Malen Ea
- Sopheany Thin
Institutions
- Burnet Institute (AU)
- Institut Pasteur (FR)
- The University of Melbourne (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Université Paris Cité (FR)
- Mahidol University (TH)
- Cambodia National Malaria Center (KH)
- Mahidol Oxford Tropical Medicine Research Unit (TH)
- Institut Pasteur du Cambodge (KH)
Publication Details
- Journal
- The Lancet Regional Health - Western Pacific
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.lanwpc.2025.101518
- Citations
- 1
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 1.88